Literature DB >> 2032295

Strategies and controversies in the treatment of gout and hyperuricaemia.

A G Fam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2032295     DOI: 10.1016/s0950-3579(05)80016-0

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


× No keyword cloud information.
  6 in total

Review 1.  Why are non-steroidal anti-inflammatory drugs so variable in their efficacy? A description of ion trapping.

Authors:  G A Ellis; D R Blake
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

2.  Missed opportunity following diagnosis of gout.

Authors:  S O'Reilly; M Doherty
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

3.  Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.

Authors:  F Perez-Ruiz; A Alonso-Ruiz; M Calabozo; A Herrero-Beites; G García-Erauskin; E Ruiz-Lucea
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

4.  Anti‑gouty arthritis and anti‑hyperuricemia properties of celery seed extracts in rodent models.

Authors:  Shaopeng Li; Lanzhou Li; Han Yan; Xue Jiang; Weiwei Hu; Ning Han; Di Wang
Journal:  Mol Med Rep       Date:  2019-09-26       Impact factor: 2.952

5.  Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.

Authors:  Chi Yin Man; Ian T F Cheung; Peter A Cameron; Timothy H Rainer
Journal:  Ann Emerg Med       Date:  2007-02-05       Impact factor: 5.721

Review 6.  Gout in the elderly. Clinical presentation and treatment.

Authors:  A G Fam
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 4.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.